FDA.reportPublic FDA data

EMTRICITABINE

Substance profile for UNII G70B4ETF4S, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for EMTRICITABINE
Structure render from PubChem CID 60877

Substance Identity#

UNII
G70B4ETF4S
Preferred term
EMTRICITABINE
Registry number
143491-57-0
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C8H10FN3O3S
Chemical structure for EMTRICITABINE
Structure render from PubChem CID 60877

Chemical And Database Identifiers#

InChIKey
XQSPYNMVSIKCOC-NTSWFWBYSA-N
SMILES
NC1=NC(=O)N(C=C1F)[C@@H]2CS[C@H](CO)O2
RxCUI
276237
PubChem
60877
NCIt
C47509
INN ID
7822

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound60877https://pubchem.ncbi.nlm.nih.gov/compound/60877
PubChem InChIKey SearchXQSPYNMVSIKCOC-NTSWFWBYSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=XQSPYNMVSIKCOC-NTSWFWBYSA-N
RxNorm276237https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=276237
NCI ThesaurusC47509https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47509
FDA Substance Registration SystemG70B4ETF4Shttps://precision.fda.gov/uniisearch/srs/unii/G70B4ETF4S

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
EMTRICITABINEACTIVE MOIETYG70B4ETF4SThese highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20121
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4SThese highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20121
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4SThese highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20063
EMTRICITABINEACTIVE MOIETYG70B4ETF4SThese highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20063
emtricitabineACTIVE INGREDIENTG70B4ETF4SThese highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA ® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20111
emtricitabineACTIVE MOIETYG70B4ETF4SThese highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA ® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20111
emtricitabineACTIVE INGREDIENTG70B4ETF4SThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20042
emtricitabineACTIVE MOIETYG70B4ETF4SThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20042
emtricitabineACTIVE INGREDIENTG70B4ETF4SThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA ® (emtricitabine) solution for oral use Initial U.S. Approval: 20031
emtricitabineACTIVE MOIETYG70B4ETF4SThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA ® (emtricitabine) solution for oral use Initial U.S. Approval: 20031
emtricitabineACTIVE INGREDIENTG70B4ETF4SThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 20042
emtricitabineACTIVE MOIETYG70B4ETF4SThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 20042
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4SThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA (emtricitabine) solution for oral use Initial U.S. Approval: 20031
emtricitabineACTIVE MOIETYG70B4ETF4SThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA (emtricitabine) solution for oral use Initial U.S. Approval: 20031
emtricitabineACTIVE MOIETYG70B4ETF4SThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 20041
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4SThese highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 20041
emtricitabineACTIVE INGREDIENTG70B4ETF4SThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA (emtricitabine) solution for oral use Initial U.S. Approval: 20031
emtricitabineACTIVE MOIETYG70B4ETF4SThese highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule for oral use EMTRIVA (emtricitabine) solution for oral use Initial U.S. Approval: 20031
emtricitabineACTIVE INGREDIENTG70B4ETF4STRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC]19
emtricitabineACTIVE MOIETYG70B4ETF4STRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC]19
EMTRICITABINEACTIVE MOIETYG70B4ETF4SATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [BRISTOL MYERS SQUIBB & GILEAD SCIENCES, LLC]17
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4SATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [BRISTOL MYERS SQUIBB & GILEAD SCIENCES, LLC]17
emtricitabineACTIVE MOIETYG70B4ETF4SCOMPLERA (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]11
emtricitabineACTIVE INGREDIENTG70B4ETF4SCOMPLERA (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]11
EMTRICITABINEACTIVE MOIETYG70B4ETF4SEMTRIVA (EMTRICITABINE) CAPSULE EMTRIVA (EMTRICITABINE) SOLUTION [GILEAD SCIENCES, INC.]7
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4SEMTRIVA (EMTRICITABINE) CAPSULE EMTRIVA (EMTRICITABINE) SOLUTION [GILEAD SCIENCES, INC.]7
emtricitabineACTIVE MOIETYG70B4ETF4SSTRIBILD (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]7
emtricitabineACTIVE INGREDIENTG70B4ETF4SSTRIBILD (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]7
EMTRICITABINEACTIVE MOIETYG70B4ETF4STRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET [CARDINAL HEALTH]3
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4STRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET [CARDINAL HEALTH]3
EMTRICITABINEACTIVE MOIETYG70B4ETF4STRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [REMEDYREPACK INC. ]3
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4STRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [REMEDYREPACK INC. ]3
EMTRICITABINEACTIVE MOIETYG70B4ETF4STRUVADA ACCESS (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC]3
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4STRUVADA ACCESS (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC]3
emtricitabineACTIVE MOIETYG70B4ETF4SATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]2
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4SATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]2
emtricitabineACTIVE MOIETYG70B4ETF4SSTRIBILD ACCESS (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]2
emtricitabineACTIVE INGREDIENTG70B4ETF4SSTRIBILD ACCESS (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]2
emtricitabineACTIVE INGREDIENTG70B4ETF4SATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
emtricitabineACTIVE MOIETYG70B4ETF4SATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4SATRIPLA ACCESS (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]1
EMTRICITABINEACTIVE MOIETYG70B4ETF4SATRIPLA ACCESS (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]1
EMTRICITABINEACTIVE INGREDIENTG70B4ETF4SCOMPLERA ACCESS (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]1
EMTRICITABINEACTIVE MOIETYG70B4ETF4SCOMPLERA ACCESS (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]1
emtricitabineACTIVE INGREDIENTG70B4ETF4SGENVOYA (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE) TABLET [GILEAD SCIENCES, INC.]1
emtricitabineACTIVE MOIETYG70B4ETF4SGENVOYA (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE) TABLET [GILEAD SCIENCES, INC.]1